Mesoporous Silica-based Nanomaterials and Biomedical Applications - Part A - 1st Edition - ISBN: 9780128151129, 9780128155219

Mesoporous Silica-based Nanomaterials and Biomedical Applications - Part A, Volume 43

1st Edition

Serial Volume Editors: Fuyuhiko Tamanoi
eBook ISBN: 9780128155219
Hardcover ISBN: 9780128151129
Imprint: Academic Press
Published Date: 24th September 2018
Page Count: 226
Sales tax will be calculated at check-out Price includes VAT/GST
114.00
79.80
79.80
79.80
91.20
79.80
79.80
91.20
159.00
111.30
111.30
111.30
127.20
111.30
111.30
127.20
110.00
77.00
77.00
77.00
88.00
77.00
77.00
88.00
222.68
155.88
155.88
155.88
178.14
155.88
155.88
178.14
Unavailable
Price includes VAT/GST

Institutional Subscription

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Table of Contents

1. Overview of Studies Regarding Mesoporous Silica Nanomaterials and Their Biomedical Application
Maria Vallet-Regi and Fuyuhiko Tamanoi
2. Structure Characterisation of Mesoporous Materials by Electron Microscopy
Yanhang Ma, Yaping Zhang, Lu Han, Shunai Che and Osamu Terasaki
3. Stimuli Responsive Nanomachines and Caps for Drug Delivery
Navnita Kumar, Wei Chen, Chi-An Cheng, Tian Deng, Wang Ruining and Jeffrey I. Zink
4. Mesoporous Silica-Based Nanoparticles for Light-Actuated Biomedical Applications via Near-Infrared Two-Photon Absorption
Jonas G. Croissant and Jean-Olivier Durand
5. Controlled Release With Emphasis on Ultrasound-Induced Release
María Vallet-Regí, Miguel Manzano and Alejandro Baeza
6. The Bioimaging Applications of Mesoporous Silica Nanoparticles
Feby Wijaya Pratiwi, Chiung Wen Kuo, Si-Han Wu, Yi-Ping Chen, Chung Yuan Mou and Peilin Chen
7. Biodistribution and Excretion of Intravenously Injected Mesoporous Silica Nanoparticles: Implications for Drug Delivery Efficiency and Safety
Mika Lindén
8. Biodegradable Silica-Based Nanoparticles: Dissolution Kinetics and Selective Bond Cleavage
Jonas G. Croissant and C. Jeffrey Brinker


Description

Cancer Therapy and Diagnosis, Part A, Volume 43 in The Enzymes series, highlights new advances in the field, with this new volume presenting interesting chapters on Mesoporous silica nanoparticle synthesis, Periodic mesoporous organosilica, Nanovalves and other nanomachine-equipped nanoparticles and controlled release, Two-photon light control and photodynamic therapy, Biodegradable PMO nanoparticles, Cationic mesoporous silica and protein delivery, Drug loading, stimuli-responsive delivery and cancer treatment, Animal models and cancer therapy, siRNA delivery and TWIST shutdown for ovarian cancer treatment, and TBC (mesoporous silica nanoparticles and cancer therapy or biodistribution of MSN).

Key Features

  • Provides the authority and expertise of leading contributors from an international board of authors
  • Presents the latest release in The Enzymes series
  • Updated release includes the latest information on Cancer Therapy and Diagnosis

Readership

Specialists in the field of Enzymes


Details

No. of pages:
226
Language:
English
Copyright:
© Academic Press 2018
Published:
Imprint:
Academic Press
eBook ISBN:
9780128155219
Hardcover ISBN:
9780128151129

Ratings and Reviews


About the Serial Volume Editors

Fuyuhiko Tamanoi Serial Volume Editor

Fuyu Tamanoi is a biochemist who has served on the UCLA School of Medicine and UCLA College faculty since he joined the Department of Microbiology, Immunology & Molecular Genetics in 1993. He became a full professor in 1997. Since 1996, he has been a Director of Signal Transduction Program Area at Jonsson Comprehensive Cancer Center. Dr. Tamanoi earned his B.S. and M.S. in Biochemistry at the University of Tokyo. He received PhD in Molecular Biology at Nagoya University in 1977. He was a postdoctoral fellow at Harvard Medical School, where he worked on bacteriophage DNA replication. From 1980 to 1985, he was a senior staff investigator at Cold Spring Harbor Laboratory, where he worked on adenovirus DNA replication. From 1985 to 1993, he was an Assistant Professor and then Associate Professor at the University of Chicago, where he initiated studies on lipid modification of the Ras family proteins. His laboratory research centers on signal transduction and signal transduction inhibitors. He is currently exploring ways to deliver signal transduction inhibitors using nanoparticles.

Affiliations and Expertise

Professor and Vice Chair, Department of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles and Director, Signal Transduction Program Area, Jonsson Comprehensive Cancer Center, USA